sagerx.com (SAGE) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Sage Therapeutics, Inc. (SAGE) markaziy nerv tizimi buzilishlarini davolash uchun dori vositalarini ishlab chiquvchi innovatsion korxonadir. Ushbu narxlar grafigi kompaniyaning neyroaktiv dori vositalarini yaratishdagi salohiyatini ko'rsatadi, bunda ko'rsatkich 0.03 darajasida turibdi. Hozirgi vaqtda biznes boshqa molekulalarning muvaffaqiyatsizligidan so'ng xarajatlarni qisqartirgan holda, yagona mahsulot savdosiga tayanmoqda. Shu bilan birga, kompaniyani hamyonbop analoglar bilan bozorga chiqarib yuborishga intilayotgan sog'liqni saqlash gigantlarining tajovuzkor bosimi xavfni yanada oshirmoqda.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_SAGE_-_Sage-Therapeutics-Inc._-_Long-Term-Debt-to-Equity-Ratio "SAGE - Sage Therapeutics Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 16.08.2025 oraligʻida | 👁️GURU.Markets👁️")
Sage Therapeutics, Inc. kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Sage Therapeutics, Inc.|SAGE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti sagerx.com|SAGE - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Sage Therapeutics, Inc.|SAGE - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarzdorlik Sage Therapeutics|Shoshilinch likvidlik sagerx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:SAGE, Sage Therapeutics Inc.
Sage Therapeutics, Inc. (SAGE) uchun neyrobiologik dori vositalarini ishlab chiqish, ular sug'urta rejalari tomonidan to'liq qabul qilinishidan oldin sezilarli moliyalashtirishni talab qiladi. Ushbu ko'rsatkich uzoq muddatli qarzlarning umumiy kapitalga nisbatini solishtirib, biznesning qarz mablag'lariga bog'liqlik darajasini aniqlaydi. Kapitaldagi uzoq muddatli majburiyatlar ulushini tahlil qilish orqali investor moliyalashtirish tuzilmasining Federal Reserve foiz stavkalari o'zgarishlariga chidamliligini baholaydi. Yuqori koeffitsiyent dori vositalarini tijoratlashtirishning sekinlashishidan kelib chiqadigan xatarlardan signal beradi. Bu esa kompaniyaning moliyaviy avtonomiyasini har tomonlama baholash imkonini beradi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|harmonybiosciences.com (HRMY) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati BHVN|Uzoq muddatli qarzning kapitalga nisbati Amylyx Pharmaceuticals Inc (AMLX)|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Praxis Corp|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ceribell.com|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alector - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|OMER (Omeros Corp.) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati NGNE|ACIU (acimmune.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com (CGTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|Cassava Sciences Inc - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ASRT|COYA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Vistagen - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Ovid Therapeutics Inc OVID|ABOS: Uzoq muddatli qarzning o'z kapitaliga nisbati|CervoMed, Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|ATHE: Uzoq muddatli qarzning kapitalga nisbati|CLNN - Uzoq muddatli qarzdorlikning kapitalga nisbati|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati jupiterneurosciences.com (JUNS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Relmada Therapeutics, Inc. (RLMD)|Uzoq muddatli qarzdorlikning kapitalga nisbati Annovis Bio Inc|Grace Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti AIFF|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NeuroSense Therapeutics NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi MTVA|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies Inc. (HSDT)|Uzoq muddatli qarzning o'z kapitaliga nisbati PASG (Passage Bio, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati bionomics.com.au|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc. NERV|Uzoq muddatli qarzdorlikning kapitalga nisbati Athira Pharma Inc (ATHA)|Addex Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|ALZN - Uzoq muddatli qarzning kapitalga nisbati|CYCN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Protagenic Therapeutics, Inc. PTIX|KTTA (Pasithea Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cortigent Medical CRGT|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics, Inc (ATXI)|BrainStorm Cell Therapeutics Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CARA (Cara Therapeutics, Inc.)|chromocell.com (CHRO) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ELYM: Uzoq muddatli qarzning o'z kapitaliga nisbati|ITCI - Uzoq muddatli qarzning kapitalga nisbati|Longboard Pharma (LBPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Marinus Pharma - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NKGen Biotech, Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati neurobopharma.com NRBO|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Uzoq muddatli qarzdorlikning kapitalga nisbati Trevena Inc.|Uzoq muddatli qarzning kapitalga nisbati VIGL (Vigil Neuroscience, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Anew Medical Inc. WENA|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati